Biomedical Advanced Research and Development Authority logo
BARDA Ventures

BARDA Ventures — Equity Co-Investment

Invests in healthcare-focused countermeasure enterprises through BARDA Ventures, advancing diagnostics, vaccines, and resilient production growth stages.

BARDA Ventures is an equity co-investment program operated jointly by the Biomedical Advanced Research and Development Authority and GHIC (Global Health Investment Corporation). It applies venture capital practices — primarily equity investment rather than grants or contracts — to accelerate companies developing transformative medical countermeasures across the full health security chain. Investme

Transformative medical countermeasure companies from seed through growth stage, spanning disease forecasting, rapid diagnostics, vaccines, therapeutics, resilient domestic manufacturing, and equitable MCM access.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Rolling
Next deadlineiThe next date applications are due. Rolling means you can apply any time.Rolling
Decision timeiTypical time from the deadline to the funder's decision.
Project durationiHow long the funded work is expected to run.
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Equity
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see the timeline

Last verified: 24 Jul 2026Source: drive.hhs.gov